key: cord-0848107-tvirnm08
authors: Chandarana, Hersh; Pisuchpen, Nisanard; Krieger, Rachel; Dane, Bari; Mikheev, Artem; Feng, Yang; Kambadakone, Avinash; Rusinek, Henry
title: Association of body composition parameters measured on CT with risk of hospitalization in patients with Covid-19
date: 2021-11-15
journal: Eur J Radiol
DOI: 10.1016/j.ejrad.2021.110031
sha: 90108b24f1e77ba5f7275b80becc5bc3fc2bb2d5
doc_id: 848107
cord_uid: tvirnm08

PURPOSE: To assess prognostic value of body composition parameters measured at CT to predict risk of hospitalization in patients with COVID-19 infection. METHODS: 177 patients with SARS-CoV-2 infection and with abdominopelvic CT were included in this retrospective IRB approved two-institution study. Patients were stratified based on disease severity as outpatients (no hospital admission) and patients who were hospitalized (inpatients). Two readers blinded to the clinical outcome segmented axial CT images at the L3 vertebral body level for visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), muscle adipose tissue (MAT), muscle mass (MM), and muscle index (MI). VAT to total adipose tissue ratio (VAT/TAT) as well as MAT/MM ratio at L3 were computed. These measures, along with detailed clinical risk factors, were compared in patients stratified by severity. Various logistic regression clinical and clinical + imaging models were compared to discriminate inpatients from outpatients. RESULTS: There were 76 outpatients (43%) and 101 inpatients. Male gender (p=0.013), age (p=0.0003), hypertension (p=0.0003), diabetes (p=0.0001), history of cardiac disease (p=0.007), VAT/TAT (p<0.0001), and MAT/MM (p<0.0001), but not BMI, were associated with hospitalization. A clinical model (age, gender, BMI) had AUC of 0.70. Addition of VAT/TAT to the clinical model improved the AUC to 0.73. Optimal model that included gender, BMI, race (Black), MI, VAT/TAT, as well as interaction between gender and VAT/TAT and gender and MAT/MM demonstrated the highest AUC of 0.83. CONCLUSION: MAT/MM and VAT/TAT provides important prognostic information in predicting patients with COVID-19 who are likely to require hospitalization.

COVID-19 illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to severe global morbidity and mortality. According to the Centers for Disease Control (CDC), between January 2020 and January 2021, over 25 million Americans have been diagnosed with COVID-19 and over 400,000 have died.

Unfortunately, the number of new cases, hospitalizations, and deaths continues to rise in the United States and worldwide. The spectrum of COVID-19 illness ranges from asymptomatic presentation to severe illness requiring hospitalization and potentially mechanical ventilation, to even death 1, 2 . Therefore, there is an urgent need to identify and validate biomarkers that are associated with severe disease and hospitalization as this may have direct impact on patient management, timely intervention, and an opportunity to reduce mortality. Reliable selection of patients that may require hospitalization can help to optimize resources and closely monitor high-risk patients. Furthermore, such evaluation and analysis may also be useful in future for other infectious and inflammatory disease processes.

Age, male sex, race, diabetes mellitus, hypertension, cardiopulmonary diseases, and obesity have been identified as risk factor for disease severity [1] [2] [3] [4] [5] [6] [7] [8] . In a recent systematic review and meta-analysis, obesity assessed by the body-mass index (BMI) has been identified as a risk factor for hospitalization, need for invasive mechanical ventilation, and death in patients with COVID-19 [9] [10] [11] . In addition to BMI, higher visceral adipose tissue (VAT) measured on CT has also been shown to be associated with hospitalization and the need for mechanical ventilation 9 . A recent small study demonstrated that the addition of VAT measured on abdominopelvic CT at the L3 level to the clinical model, which included age, sex, and BMI, improved discrimination between hospitalized patients and outpatients 12 . This study found no significant correlation between VAT and BMI, which implied that VAT provides important information about obesity and patient's metabolic health that is not captured by BMI.

It is well known that sarcopenia, muscle fat or steatosis, and low muscle mass are associated with poor outcome in patients with malignancy and in critically ill patients [13] [14] [15] .

A recent study has shown that lower volume and density of the pectoralis muscle on chest CT was associated with severe COVID-19 disease 16 . Similarly, decreased attenuation of skeletal muscle was associated with disease severity in the hospitalized patients 17 .

Measures of cross sectional muscle area (muscle mass, MM) and muscle adipose tissue (MAT) may thus serve as biomarkers of overall health, and lower MM and higher MAT may suggest poor health.

The purpose of our two-center study, motivated by this evidence, was two-fold:

(1) Evaluate if the ratio of muscle adipose tissue (MAT) to MM (MAT/MM) measured at abdominopelvic CT is higher in patients with COVID-19 who required hospitalization compared to the outpatients, and (2) test if a model that includes MAT/MM in addition to CT measures of VAT can improve identification of patients that require hospitalization.

We first tested the model in a pooled cohort, then trained it on data from one center and tested on the other to examine the model's robustness against heterogeneity of patient populations and CT acquisitions.

This HIPAA-compliant, retrospective, two-institution study (institutions A and B, located in different cities) was approved by each institution's review board and received a waiver of informed consent. At each institution, a retrospective search of the patient database was performed to identify all adults (≥ 18 years of age) who had a diagnosis of SARS-CoV-2 infection during the period of March to June 2020. Inclusion criteria for the study was patients with diagnosis of SARS-CoV-2 infection who either underwent abdominopelvic CT during their acute presentation of SARS-CoV-2 infection or had prior abdominopelvic CT performed within 6 months of the diagnosis of SARS-CoV-2 infection. Exclusion criteria were patients whose CT exams showed poor image quality and extensive ascites. In patients with multiple exams, the CT exam closest to the acute presentation was selected.

March to June 2020. Among these, 176 abdominopelvic CT exams were performed either during acute presentation or within 6 months prior to the acute presentation. After excluding repeat exams, exams with incomplete abdominopelvic imaging, or with suboptimal image quality, the study cohort at institution A consisted of 99 patients. The electronic medical record (EMR) was reviewed to obtain the clinical outcome of COVID-19 disease and categorize patients based on disease severity into two groups: (1) patients who did not require hospital admission (outpatients), and (2) patients who were hospitalized (inpatients) due to severe COVID-19 illness. There were 62 inpatients and previously published study (BLINDED) . Similarly, at institution B, 1700 patients were diagnosed with SARS-CoV-2 infection during the same time period, and 252 abdominopelvic CT examination were performed in these patients. After excluding repeat exams and exams with poor image quality, a subset of patients from institution B consisted of 39 inpatients and 39 outpatients were randomly selected. Thus, 99 patients from institution A and 78 patients from an institution B were included for a total combined cohort of 177 patients.

Data on age, sex, race/ethnicity, BMI, hypertension (HTN), diabetes mellitus (DM), history of pulmonary disease, and cardiac disease were collected in all patients from EMR.

Abdominopelvic CT examinations were acquired in supine position on a variety of stateof-the-art 64-slice or 128-slice multi-detector scanners. Axial images through the abdomen were constructed on the scanner console. Section thickness averaged 3.7 mm (range, 2.5 -5 mm). 69% of CT exams (122 out of 177) were performed with intravenous contrast.

The goal of quantitative CT image analysis workflow is to reliably and quickly estimate the composition of abdominal fat and muscle. At each institution, segmentation and quantitative adipose tissue analyses were performed by a reader who was blinded to the clinical outcome. Processing was done using FireVoxel (build 314), a freely available software (www.firevoxel.org).

In the first step, the observer located the CT slice corresponding to the superior endplate of the L3 vertebral body. This was facilitated by sagittal and coronal projections of the axial image stack. In the next step, the observer then drew the interior boundary (C) of the abdominal wall (red contour in Figure 1 ). Subsequent steps are applied automatically. In these steps, median filtering, background detection and connectivity are used to mask out features that are external to the abdomen, including the patient's arms, clothing, tubes, and supporting table. Morphological erosion was used to further exclude the 2.2-mm layer of abdominal skin. The resulting tissue was thresholded to [-150, +73] Hounsfield units (HU) attenuation range. A further threshold of -10 HU and morphological noise removal was used to define the muscle (> -10 HU) and total abdominal fat compartments. Finally, the location with respect to the contour C and the topological relationship to the muscle were applied to partition the total fat into (a) subcutaneous, (b) visceral, and (c) muscle fat compartments ( Figure 1 ). In the final manual step, the operator checks and corrects muscle ROI by erasing a small area in spinal medullary canal that can be erroneously classified as muscle.

Measures of adipose tissue area VAT, subcutaneous adipose tissue (SAT), MAT (computed at the L3 vertebral body level) were obtained from the segmented areas at the L3 vertebral body level. Cross-sectional area of muscle tissue at the L3 level was defined as Muscle Mass (MM). Mean muscle index (MI) which is the MM normalized to height 2 was computed. Ratios of MAT/MM and VAT to total value TAT = SAT +VAT + MAT were also computed.

Clinically acceptable speed (1-2 min per exam) and inter-observer reliability of CT segmentation workflow has been reported previously (BLINDED).

In the initial analysis, age, sex, race, BMI, and raw measures of abdominal tissue In the next step, we built multivariate models to predict which patients would require hospitalization. Based on the initial analyses, we selected as potential predictors age, sex, race (Black or not Black), BMI, MI, and VAT/TAT. Abdominal tissue distribution is known to depend on sex and race, and thus we also considered two types of interactions: VAT/TAT versus sex/race and MAT/MM versus sex/race. Using the best subset selection approach, we have constructed the logistic regression model defined as the model with the smallest value of Akaike information criterion (AIC) 18 among all subsets. This optimal model was compared to 1) a clinical model that included age, sex, and BMI, and to 2) a previously proposed clinical + CT model that included age, sex, BMI, and VAT/TAT 12 . Receiver operating characteristic (ROC) analysis was performed and the area under the curve (AUC) was computed for each of these models. The comparison between the AUCs was performed using the DeLong method 19 . For each model and each predictor, we computed the odds ratio. In addition, leave-one-out crossvalidation was also performed in conjunction with each model fit for a more realistic estimate on how the model is likely to perform in a new setting. MedCalc (version 19.2.6) and R (version 3.6.3) were used to perform statistical analyses.

The mean ± stdev age of the patients was 59±16 years; 80 patients (45%) were female and 97 patients were male (55%). Out of the 177 patients, 76 were outpatients (43%) and 101 were inpatients (57% Hispanic, 6% Asian, and 11% other/nonspecific. We did not find statistically significant differences in the proportion of inpatients by ethnicity. (Table 1) . This difference was statistically significant for patients with history of heart disease (p=0.007), but did not reach significance for patients with pulmonary disease (p=0.067).

Muscle adiposity: There was a larger amount (area in cm 2 ) of muscle adipose tissue (MAT) in inpatients compared to the outpatients (17.8 ± 9.4 cm 2 vs. 12.1 ± 7.0 cm 2 ; p<0.001). There was no significant difference in the muscle area (measured in cm 2 ) at the L3 level between inpatients and outpatients (122.7 ± 34.5 cm 2 vs. 131.0 ± 32.8 cm 2 ; p=0.112). However, mean muscle index (MM normalized to height 2 ) was significantly smaller for inpatients (0.00437 ± 0.00118) than for outpatients (0.00482 ± 0.00119, p=0.012). MAT/MM ratio was significantly higher in the inpatients compared to the outpatients (0.131 ± 0.070 vs. 0.088 ± 0.054; p<0.001). When stratified by sex, MAT/MM was significantly higher in hospitalized males (p<0.001) and hospitalized females (p=0.002) compared to the outpatient males and females, respectively ( Figure 2A ).

There was no significant correlation between BMI and MAT/MM (r=0.13; p=0.113).

Adipose tissue: VAT (234.8 ± 112.1 cm 2 vs. 157.9 ± 92.4 cm 2 ; p<0.001) and VAT/TAT (0.48 ± 0.14 vs. 0.38 ± 0.16; p<0.001) were significantly higher in inpatients compared to the outpatients. Furthermore, these measures when stratified by sex were significantly different in hospitalized women compared to the outpatient women (p<0.001), but were not significantly different in hospitalized and outpatient men (p=0.39). These differences are illustrated by a box plot in Figure 2B .

Correlation between MAT/MM and VAT/TAT: There was no significant correlation between MAT/MM and VAT/TAT (r=0.04; p=0.692). Some studies have suggested that Black and Latino patients have higher incidence and greater severity of the disease 20,21 . Our multivariate model also confirmed an independent risk associated with race (Black or not Black), but this risk was much lower (nearly 4 times) than the risk of male gender. Furthermore, in a large study of six million US veterans, 30-day mortality did not differ by race or ethnicity 22 . Similarly, in a recent study, among those who tested positive for COVID-19, the odds of hospitalization were similar among White, Hispanic, and Black patients. In addition, hospitalized Black patients were less likely than White patients to have severe disease or die from the disease 23 . These studies suggest that mortality in some patients may be related to not having access to timely healthcare and hospital admission rather than underlying differences by ethnicity or race. Hence, being able to predict which patients would require hospitalization may potentially improve the outcome by triaging sicker patients to the hospital care while observing others as outpatients. Furthermore, with introduction of vaccines against SARS-CoV-2, identifying at-risk patients for hospitalization can help guide the order of vaccine deployment.

Obesity is associated with worse outcome in patients with COVID-19, including hospitalization and need for mechanical ventilation 9, 11 . In our cohort, higher VAT/TAT was associated with hospitalization, both in male and female patients, but with higher odds ratio in female subjects. In a recent study, lower volume and density of pectoralis muscle were associated with poor outcome in patients with COVID-19 16 . Similarly, pectoralis muscle area and muscle index were associated with disease severity including death 24 . Deposition of fat in the muscle is an indicator of muscle wasting. In our study, higher MAT and MAT/MM ratio at the L3 level were associated with increased risk of hospitalization, and had higher odds ratio in male subjects. It is important to note that MAT/MM at L3 level was not significantly correlated with BMI or VAT/TAT. Hence MAT/MM provides different and synergistic information relative to BMI and visceral adiposity.

In our cohort, HTN, DM, and history of cardiac disease was significantly associated with hospitalization. Furthermore, although higher percentage of patients with history of pulmonary were also hospitalized, this difference was not statistically significant, possibly due to a small sample size. Moreover, when compared against the model that included body composition parameters in addition to gender and race, these clinical risk factors did not appear to provide an independent risk of hospitalization in a multi-factorial model. It is also surprising that after accounting for gender and abdominal tissue biomarkers, subject age did not constitute an independent risk for hospitalization.

A recent study evaluated the combined role of VAT and muscle adiposity in predicting critical illness in hospitalized patients with COVID-19 17 . In this interesting study, VAT and skeletal muscle attenuation were associated with disease severity in the hospitalized patients, and with the need for mechanical ventilation and death. However, to our knowledge, no study has evaluated the role of combination of MAT/MM and VAT/TAT measured at the L3 vertebral body level on abdominopelvic CT in predicting the need for hospitalization in COVID-19 patients. Our study focuses on identifying subjects that may need hospitalization rather than severity of disease in hospitalized patients, and we believe that this information is complementary when considering resource allocation and utilization. Additional strength of our study is having data available from two institutions in different cities in the United States. We believe that this heterogeneity of data from two institutions will make our model more generalizable and robust. Furthermore, in our study we directly measured muscle mass and MAT instead of muscle attenuation which hopefully is less influenced by anasarca and edema.

Our study had a number of limitations. It is retrospective in nature, and this model has not been evaluated prospectively to predict the need for hospitalization. Not all patients with COVID-19 will have abdominopelvic CT available or will undergo abdominopelvic CT, and hence it might be difficult to apply this model to a wider cohort of patients with COVID-19. However, patients with CT performed previously for any indication can be utilized to extract MAT/MM and VAT/TAT. Presence of edema and anasarca can impact identifying fat voxels both in the subcutaneous tissues as well as in the muscle, thus limiting the accuracy of segmented adipose tissues. We used a single slice evaluation for computing body composition parameters. Some of our studies were performed without contrast and slice thickness for Ct exam ranged between 2.5 and 5mm. However, presence or lack of intravenous contrast and CT slice thickness in the range of 2.5 mm and 5 mm does not seem to impact the accuracy of adipose tissue and muscle mass segmentation (see Supplemental Section). . There has been recent work in developing deep learning based segmentation methods that also can be incorporated in such analysis 25, 26 . In a recently published study, measure of muscle and visceral adiposity on chest CT at T7-T8 level was also associated with risk of hospitalization, mechanical ventilation and death 27 . In the future, we plan to develop a model that includes various measures of muscle adiposity and visceral adiposity on chest CT in addition to abdominopelvic CT to predict the need for hospitalization in patients that have chest CT but not abdominopelvic CT.

We have shown that muscle adipose tissue and the ratio of muscle adipose tissue to muscle mass measured at the L3 vertebral body level is significantly different in hospitalized patients compared to the outpatients. Furthermore, a model that includes MAT/MM in addition to visceral adiposity measures at the L3 vertebral body could help to identify patients who may require hospitalization. For MAT/MM x gender, the odds ratio corresponds to a 1% increase in MAT/MM.

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the

Clinical and immunological features of severe and moderate coronavirus disease 2019

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A datadriven analysis in the early phase of the outbreak

Association of Obesity with Disease Severity among Patients with COVID-19

SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects

Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis

Obesity a predictor of outcomes of COVID-19 hospitalized patients-A systematic review and meta-analysis

Obesity in patients with COVID-19: a systematic review and meta-analysis

Visceral adipose tissue in patients with COVID-19: risk stratification for severity. Abdom Radiol (NY)

Skeletal Muscle Composition Predicts Outcome in Critically Ill Patients

The Predictive Value of Low Muscle Mass as Measured on CT Scans for Postoperative Complications and Mortality in Gastric Cancer Patients: A Systematic Review and Meta-Analysis

CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis

Correlation of Pectoralis Muscle Volume and Density with Severity of COVID-19 Pneumonia in Adults

Visceral Adiposity and High Intramuscular Fat Deposition Independently Predict Critical Illness in Patients with SARS-CoV-2. Obesity (Silver Spring)

Information theory and an extension of the maximum likelihood principle

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity -United States

The National COVID Cohort Collaborative: Clinical Characterization and Early Severity Prediction. medRxiv

Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans. medRxiv

Assessment of Racial/Ethnic Disparities in Hospitalization and Mortality in Patients With COVID-19 in New York City

The prognostic value of pneumonia severity score and pectoralis muscle Area on chest CT in adult COVID-19 patients

Automated Abdominal Segmentation of CT Scans for Body Composition Analysis Using Deep Learning

Population-Scale CT-based Body Composition Analysis of a Large Outpatient Population Using Deep Learning to Derive Age-, Sex-, and Race-specific Reference Curves

Credit Author Statement Hersh Chandarana: Conceptualization, Methodology, Project Administration, Resources, Writing Original Draft Nisanard Pisuchpen: Data curation, Investigation, Revising/Editing Draft Rachel Kriege: Data curation, Investigation, Revising/Editing Draft Bari Dane: Data curation, Investigation, Supervision, Revising/Editing Draft Artem Mikheev: Software, Investigation, Revising/Editing Draft Yang Feng: Formal Analysis, Revising/Editing Draft Avinash Kambadakone: Data Curation

Funding: This work is supported in part by the National Institute of Health (NIH) Grant U24 EB028980